IIC
BIIB icon

Integrated Investment Consultants’s Biogen BIIB Stock Holding History

Integrated Investment Consultants’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-177
Closed -$48K – 222
2018
Q1 		$48K Buy
+177
New +$54.9K 0.02% 433
2017
Q3 		$36K Buy
115
+4
+4% +$1.18K 0.02% 419
2017
Q2 		$30K Hold
111
– – 0.01% 429
2017
Q1 		$30K Hold
111
– – 0.01% 427
2016
Q4 		$31K Buy
111
+14
+14% +$4.15K 0.01% 422
2016
Q3 		$29K Hold
97
– – 0.01% 431
2016
Q2 		$23K Hold
97
– – 0.01% 457
2016
Q1 		$26K Buy
+97
New +$25.6K 0.02% 424

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Integrated Investment Consultants's BIIB Position: Q2 2018 in Review

Integrated Investment Consultants sold out of Biogen (BIIB) in Q2 2018, closing a stake of 177 shares — an estimated $48K sold.

Integrated Investment Consultants first reported a position in BIIB in Q1 2016 and held it in 8 quarters. The position peaked at $48K in Q1 2018. 1,097 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

  • Integrated Investment Consultants reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
  • Integrated Investment Consultants sold 177 Biogen shares in Q2 2018, an estimated $48K.
  • Integrated Investment Consultants first reported a position in Biogen in Q1 2016 and held it in 8 quarters.
  • Integrated Investment Consultants's Biogen position peaked at $48K in Q1 2018.
  • 1,097 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on Integrated Investment Consultants's 13F filing for Q2 2018, filed 1 Aug 2018.